Abiomed

Content on this page requires a newer version of Adobe Flash Player.

Get Adobe Flash player

Abiomed ( ABMD) is a provider of medical devices in circulatory support and offers a continuum of care in heart recovery to acute heart failure patients. This stock is trading up 3.5% to $21.33 in recent trading after hitting a 52-week high of $21.50 earlier in the day.

Today's Range: $20.84-$21.50

52-Week Range: $8.97-$21.50

Volume: 153,000

Three-Month Average Volume: 265,486

Abiomed has a market cap of $804 million and an enterprise value of $715 million. This stock trades at a forward price-to-earnings of 125.76. Its estimated growth rate for this year is 78.1%, and for next year it's pegged at 342.9%. The current short interest as a percentage of the float for Abiomed is 6.7%.

From a technical standpoint, ABMD has recently triggered a big breakout trade once the stock cleared some past overhead resistance level at $20.

>>5 Stocks Setting Up to Break Out

Market players should watch for ABMD to continue its trend higher since the stock has held above that key breakout level for a number of trading sessions. As long as ABMD stays above $20 and volume patterns remain decent to strong, then this stock should have a date with $25 in the near future.

If you liked this article you might like

Cramer's 6 Stocks in 60 Seconds: GOGO AGN CTAS BYI DECK HCA (Update 1)

Bally Technology Shuffles SHFL in $1.3B Deal

Cramer's 'Mad Money' Recap: Next Week's Game Plan

Two Speculative Long-Side Trades

Two Speculative Long-Side Trades

Stock Futures Gain Momentum